Intrommune Therapeutics
Intrommune is developing prescription and consumer solutions to counter the global health burden of food allergies and their life-threatening consequences.
- Stage Full Product Ready
- Industry Biotechnology
- Location New York, NY, USA
- Currency USD
- Founded December 2013
- Employees 3
- Incorporation Type C-corp
- Website intrommune.com
Company Summary
Intrommune is developing safe, effective, and easy-to-use solutions to counter the global health burden of food allergies and their life-threatening consequences. Its core OMIT Platform technology enables self-administration of treatment via a specially formulated toothpaste that incorporates and stabilizes proteins. Immunomodulatory agents are delivered throughout the oral cavity to efficiently and safely drive the immune system toward tolerance
Team
-
CEO -
CSO -
Director of Strategy and Medical Affairs -
Controller
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.